Sector consensus Northwest Biotherapeutics, Inc. Börse Stuttgart
Stocks
NBYB
US66737P6007
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1500 EUR | 0.00% |
|
-6.25% | -27.18% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 886.67 | +16.48% | 15 | ||||||
| 150.47 | +18.01% | 18 | ||||||
| 196.33 | +78.31% | 21 | ||||||
| 106.79 | +35.06% | 20 | ||||||
| 40.61 | +23.03% | 23 | ||||||
| 2,333.28 | +25.44% | 15 | ||||||
| 1,057.48 | -11.88% | 7 | ||||||
| 547.64 | +9.92% | 17 | ||||||
| 51.19 | -8.22% | 16 | ||||||
| 678.71 | +26.42% | 14 | ||||||
| 21.41 | +83.43% | 13 | ||||||
| 148.83 | +79.49% | 20 | ||||||
| 107.8 | +31.58% | 20 | ||||||
| 91.25 | +26.89% | 12 | ||||||
| 125.12 | +0.94% | 16 | ||||||
| 99.84 | +39.58% | 14 | ||||||
| 82.5 | -1.45% | 10 | ||||||
| 103.93 | +5.04% | 15 | ||||||
| 109 | +93.92% | 9 | ||||||
| Average | 365.2 | +30.11% | 16 | ||||||
| Weighted average by Cap. | 433.89 | +27.43% | 16 |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
